AutoIVF Awarded NIH SBIR Grant to Advance Commercialization of OvaReady

August 07, 2025 at 08:00 AM EDT

AutoIVF Inc., a fertility technology company committed to expanding access to assisted reproductive care, announced it has been awarded a Phase IIB Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH). This latest award is supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development under Award Number R44HD105529.

The NIH grant will support commercialization of AutoIVF’s flagship platform, OvaReady, an automated desktop system intended to streamline the egg identification and preparation process for in vitro fertilization (IVF). The platform is being developed to support the decentralization of egg retrieval, with the goal of expanding access to fertility care beyond traditional IVF lab settings. The device is currently in development and is not yet available for sale in the United States.

“The NIH’s sustained support over the past five years—from early feasibility to commercialization—reinforces the scientific merit and clinical potential of our approach,” said Emre Ozkumur, Ph.D., Vice President of R&D at AutoIVF. “We’re proud to be driving innovations intended to improve care for patients undergoing infertility treatment or fertility preservation.”

Led by CEO Ravi Kapur, Ph.D., FAIMBE, AutoIVF’s team brings together more than 200 years of combined experience in IVF, microfluidics, and reproductive health. The company is focused on transforming access to fertility care globally.

“Being selected through the NIH’s highly competitive review process shows the real potential the technology has to improve outcomes for patients, doctors, and the broader fertility field,” said co-founders Drs. Thomas Toth, Michael Alper, and Alan Penzias. “With decades of experience as IVF physicians, we see OvaReady as a game changer - making it easier and more efficient to identify and prepare eggs for IVF and fertility preservation.”

About AutoIVF

AutoIVF Inc., headquartered in Natick, Massachusetts, is advancing the future of fertility care through cutting-edge innovation, intelligent automation, and a commitment to broadening access. Its flagship system, OvaReady, is designed to streamline and enhance the egg identification and preparation process in IVF.